You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 151 No. 3, MARCH 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Refractory Hypoglycemia Secondary to Topical Salicylate Intoxication

Robert Raschke, MD; Patricia A. Arnold-Capell, PharmD; Robert Richeson, MD; Steven C. Curry, MD

Arch Intern Med. 1991;151(3):591-593.


Abstract

We describe a case of severe refractory hypoglycemia secondary to topical salicylate intoxication. A 72-year-old man with psoriasis and end-stage renal disease was treated with a topical cream containing 10% salicylic acid. The patient presented with encephalopathy and subsequently developed hypoglycemia refractory to infusions of large amounts of glucose. A serum salicylate concentration was elevated at 3.2 mmol/L. Emergent hemodialysis was accompanied by rapid lowering of serum salicylate concentration and resolution of refractory hypoglycemia. Salicylate is well absorbed across normal and diseased skin. Salicylate markedly impairs gluconeogenesis and increases glucose utilization, resulting in hypoglycemia. To our knowledge, this is the first article on hypoglycemia due to the application of topical salicylate.

(Arch Intern Med. 1991;151:591-593)



Author Affiliations

From the Departments of Internal Medicine (Drs Raschke, Richeson, Curry) Pharmacy (Dr Arnold-Capell), and Medical Toxicology (Dr Curry), Good Samaritan Regional Medical Center, Phoenix, Ariz.


Footnotes

Accepted for publication December 7, 1989.

Reprint requests to the Department of Pharmacy, Good Samaritan Regional Medical Center, 1111 E McDowell Rd, Phoenix, AZ 85006 (Dr Arnold-Capell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An old patient with end stage renal disease and sudden onset of confusion and lethargy
Pistrosch et al.
Nephrol Dial Transplant 2006;21:813-815.
FULL TEXT  

A serious complication of topical wart treatment on the hand
Tavakkolizadeh and Povlsen
JRSM 2004;97:180-180.
FULL TEXT  

Safety Assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate
International Journal of Toxicology 2003;22:1-108.
ABSTRACT  

Insulinoma in Chronic Renal Failure: A Case Report
Basu et al.
J. Clin. Endocrinol. Metab. 2002;87:4889-4891.
ABSTRACT | FULL TEXT  

Hypoglycemic Disorders
Service
NEJM 1995;332:1144-1152.
FULL TEXT  

Refractory Hypoglycemia: A Complication of Topical Salicylate Therapy
Maurer et al.
Arch Dermatol 1994;130:1455-1457.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.